NCT02907099 2025-02-19Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic CancerM.D. Anderson Cancer CenterPhase 2 Completed20 enrolled 12 charts
NCT02639559 2023-11-07Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological MalignanciesWashington University School of MedicinePhase 2 Completed50 enrolled 23 charts